Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle

被引:216
作者
Mote, PA [1 ]
Balleine, RL [1 ]
McGowan, EM [1 ]
Clarke, CL [1 ]
机构
[1] Univ Sydney, Westmead Hosp, Westmead Inst Canc Res, Westmead, NSW 2145, Australia
关键词
D O I
10.1210/jc.84.8.2963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The human progesterone receptor (PR) is expressed as two isoforms, PRA and PRE, that function as ligand-activated transcription factors. In vitro studies suggest that the isoforms differ functionally and that the relative levels in a target cell may determine the nature and magnitude of response to progesterone. However, it is not known whether the two isoforms are normally coexpressed in vivo. To understand the functional significance of relative PR isoform expression in normal physiology, it is essential to determine whether PRA and PRE are coexpressed in the same cell. This study reports the development of a dual immunofluorescent staining technique to demonstrate PRA and PRE proteins by single cell analysis in the same tissue section of human endometrium during the menstrual cycle. PRA and PRE are coexpressed in target cells of the human uterus. In the glands, PRA and PRE were expressed before subnuclear vacuole formation and glycogenolysis, implicating both isoforms in this process, whereas persistence of PRE during the midsecretory phase suggested its significance in glandular secretion. In the stroma, the predominance of PRA throughout the cycle implicates this isoform in postovulatory progesterone-mediated events. These results support the view that PRA. and PRE mediate distinct pathways of progesterone action in the glandular epithelium and stroma of the human uterus throughout the menstrual cycle.
引用
收藏
页码:2963 / 2971
页数:9
相关论文
共 48 条
[1]   PROGESTIN INHIBITION OF PROGESTERONE-RECEPTOR GENE-EXPRESSION IN HUMAN-BREAST CANCER-CELLS [J].
ALEXANDER, IE ;
CLARKE, CL ;
SHINE, J ;
SUTHERLAND, RL .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) :1377-1386
[2]  
BERGERON C, 1988, LAB INVEST, V59, P862
[3]  
BRENNER RM, 1991, ANN NY ACAD SCI, V622, P149
[4]  
Clark J H, 1979, Monogr Endocrinol, V14, pI
[5]   MONOCLONAL-ANTIBODIES TO HUMAN PROGESTERONE-RECEPTOR - CHARACTERIZATION BY BIOCHEMICAL AND IMMUNOHISTOCHEMICAL TECHNIQUES [J].
CLARKE, CL ;
ZAINO, RJ ;
FEIL, PD ;
MILLER, JV ;
STECK, ME ;
OHLSSONWILHELM, BM ;
SATYASWAROOP, PG .
ENDOCRINOLOGY, 1987, 121 (03) :1123-1132
[6]  
DALLENBACHHELLW.G, 1975, HISTOPATHOLOGY ENDOM, P22
[7]  
DEMOPOULOS RI, 1982, PATHOLOGY FEMALE GEN, P235
[8]   PROGESTIN-MEDIATED CHANGES IN PROGESTERONE-RECEPTOR FORMS IN THE NORMAL HUMAN-ENDOMETRIUM [J].
FEIL, PD ;
CLARKE, CL ;
SATYASWAROOP, PG .
ENDOCRINOLOGY, 1988, 123 (05) :2506-2513
[9]   STUDY OF ESTROGEN AND PROGESTERONE RECEPTORS IN NORMAL HUMAN ENDOMETRIUM DURING THE MENSTRUAL-CYCLE BY IMMUNOCYTOCHEMICAL ANALYSIS [J].
FUNG, HYM ;
WONG, YL ;
WONG, FWS ;
ROGERS, MS .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1994, 38 (03) :186-190
[10]   USE OF IMMUNOCYTOCHEMISTRY OF PROGESTERONE AND ESTROGEN-RECEPTORS FOR ENDOMETRIAL DATING [J].
GARCIA, E ;
BOUCHARD, P ;
DEBRUX, J ;
BERDAH, J ;
FRYDMAN, R ;
SCHAISON, G ;
MILGROM, E ;
PERROTAPPLANAT, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :80-87